Monitoring of circulating tumour-associated DNA as a prognostic tool for oral squamous cell carcinoma
2005

Monitoring Tumor DNA for Oral Cancer Prognosis

Sample size: 64 publication Evidence: moderate

Author Information

Author(s): Hamana K, Uzawa K, Ogawara K, Shiiba M, Bukawa H, Yokoe H, Tanzawa H

Primary Institution: Chiba University

Hypothesis

Can monitoring circulating tumour-associated DNA predict the prognosis of oral squamous cell carcinoma?

Conclusion

The study suggests that assessing microsatellite status in serum DNA could be a useful predictive tool for monitoring disease prognosis in oral squamous cell carcinoma.

Supporting Evidence

  • 59% of DNA samples from tumorous tissues showed allelic imbalances.
  • 44% of patients had detectable AI in serum preoperatively.
  • 71% of patients with AI preoperatively had no evidence of AI postoperatively.

Takeaway

Doctors can check for special DNA changes in the blood of patients with oral cancer to see how likely they are to get better or worse.

Methodology

The study analyzed serum DNA from 64 patients at three time points using nine microsatellite markers.

Limitations

The study is based on a small sample size and is a pilot study.

Participant Demographics

38 males and 26 females; mean age 68 years; range 39–81 years.

Statistical Information

P-Value

0.0378

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1038/sj.bjc.6602635

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication